跳至主要内容
临床试验/CTRI/2023/03/050170
CTRI/2023/03/050170Other未知

OUTCOME OF PROTON PUMP INHIBITOR CO-ADMINISTRATION WITH DUALANTIPLATELET THERAPY IN THE MANAGEMENT OF ATHEROSCLEROTICCARDIOVASCULAR DISEASE: A RETROSPECTIVE REAL-WORLD STUDY

Dr Reddys Laboratories Ltd0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
Other
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients with documented history of atherosclerotic cardiovascular disease using dual antiplatelet drugs along with PPIs

排除标准

  • Patients with a history of peptic ulcer or gastric or duodenal surgery
  • Patients with erosive esophagitis and gastric-outlet obstruction
  • Patients treated with multiple anti-ulcer medications
  • Patients with severe pulmonary, hepatic, or renal disease
  • Patients with incomplete records
  • Patients on anticoagulants other than aspirin plus clopidogrel and on PPIs other than rabeprazole, pantoprazole and esomeprazole.

研究者

相似试验